FDA launches patient-focused drug development 2.0

FDA Tuesday published the first of four planned guidance documents that aim to move patient-focused drug development from listening sessions to a set of scientifically robust methods that can be integrated into product development.

The guidance documents

Read the full 377 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE